Subscribe to FREE Stock Market News Alerts by visiting: http://www.PennyStockPickReport.com
CareFusion Corporation (NYSE:CFN) rose 6.21% to $23.95 after the San Diego medical-device company spun out of Cardinal Health's clinical and medical-product businesses, reported fiscal first-quarter fell 28%, earnings from continuing operations rose 83%, and revenue rose 0.9%. Net income was $81 million, or 37 cents a share, compared with $113 million, or 51 cents, in the year-earlier quarter. From continuing operations, the company earned 25 cents a share against 14 cents. Adjusted earnings in the latest quarter were up 71%, to 39 cents a share. Revenue reached $923 million from $915 million. A survey of analysts by FactSet Research produced consensus estimates of 23 cents of profit on $945.8 million of revenue. The company raised its estimate of earnings for the full year to a range of $1.35 to $1.45 from a range of $1.10 to $1.20.
CareFusion Corporation (CareFusion) is a global medical technology company. The Company offers product lines in the areas of intravenous (IV) infusion, medication and supply dispensing, respiratory care, infection prevention and surgical instruments.